Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 7/20 | 0.59 |
| ▸ | PARP1 | P09874 | 4/20 | 0.59 |
| ▸ | TNKS2 | Q9H2K2 | 4/20 | 0.59 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.56 |
| ▸ | GABRP | O00591 | 2/20 | 0.56 |
| ▸ | GABRD | O14764 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29380373 | 1.00 | TNKS (0.59) | TNKSPARP1TNKS2MAOBPARP2 | |
| SCHEMBL30876961 | 0.85 | ACHE (0.49) | TNKSPARP1TNKS2MAOBPARP2 | |
| Ethyl Acetate SCHEMBL11110265 | 0.83 | KDM4E (0.60) | TNKSMAOBACHEHPGDSMN1; SMN2 | |
| SCHEMBL31217562 | 0.79 | ACHE (0.58) | TNKSACHEHPGDSMN1; SMN2CYP3A4 | |
| 2,7-Dimethylchromone SCHEMBL7600130 | 0.78 | ALDH1A1 (0.64) | TNKSPARP1TNKS2MAOBPARP2 | |
| SCHEMBL266614 | 0.78 | MAPT (0.63) | ACHEHPGDSMN1; SMN2NPC1RAB9A | |
| Flavone SCHEMBL27560931 | 0.77 | TNKS (0.85) | TNKSPARP1TNKS2MAOBPARP2 | |
| SCHEMBL4373327 | 0.76 | HPGD (0.45) | TNKSMAOBACHEHPGDSMN1; SMN2 | |
| SCHEMBL5340573 | 0.76 | TNKS (0.59) | TNKSPARP1TNKS2MAOBPARP2 | |
| SCHEMBL10654593 | 0.76 | CYP3A4 (0.78) | TNKSPARP1TNKS2MAOBPARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119019483-A | Methyl chromone compound and preparation method and application thereof | 石家庄以岭药业股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-117567419-A | Synthesis method of 3-amine methyl primary ketone derivative | 深圳职业技术大学 | 2024-02-20 | — | — | CN | claimed |
| CN-113527244-B | 5-methyl chromone derivative and synthetic method and application thereof | 海南医学院 | 2023-02-03 | — | — | CN | claimed |
| CN-108558859-B | Preparation and application of visible long-wave Hg2+ fluorescent probe based on benzopyran | 湖北大学 | 2021-08-24 | — | — | CN | claimed |
| CN-106478576-B | A kind of fluorescence probe and the preparation method and application thereof for detecting carboxy-lesterase | 华南理工大学 | 2019-01-18 | — | — | CN | claimed |
| CN-106478576-A | A kind of for detecting fluorescence probe of carboxy-lesterase and preparation method and application | 华南理工大学 | 2017-03-08 | — | — | CN | claimed |
| CN-106107406-A | Improve the method for the stability of sweetness enhancers and comprise the compositions of stable sweetness enhancers | 赛诺米克斯公司 | 2016-11-16 | — | — | CN | claimed |
| CN-105327336-A | Chinese herbal medicine containing herba catharanthi rosei, aloes, radix zanthoxyli and mint, skin absorbable lotion and diet therapy | XIE YOUZHU | 2016-02-17 | — | — | CN | claimed |
| CN-103153096-A | Methods of improving the stability of sweetness enhancers and compositions comprising stable sweetness enhancers | SENOMYX INC | 2013-06-12 | — | — | CN | claimed |
| US-4513145-A | BACTERICIDES, URINARY TRACT DISORDERS; CEPH M INTERMEDIATES | EISAI CO., LTD. (JP) | 1985-04-23 | — | — | US | claimed |
| EP-0114899-A1 | 2-Methylchromone derivatives and their preparation process | Eisai Co., Ltd. (JP) | 1984-08-08 | — | — | EP | claimed |
| JP-63030483-A | — | — | None | — | — | JP | disclosed |
| WO-2025129358-A1 | STABLE FILM FORMULATIONS FOR HIGH LOADING OF LOW MELTING POINT ACTIVES | INTELGENX CORP. (CA) | 2025-06-26 | — | — | WO | disclosed |
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | Ryvu Therapeutics S.A. (PL) | 2024-12-10 | — | — | US | disclosed |
| CN-119019483-A | Methyl chromone compound and preparation method and application thereof | 石家庄以岭药业股份有限公司 | 2024-11-26 | — | — | CN | disclosed |
| EP-0114899-A1 | 2-Methylchromone derivatives and their preparation process | Eisai Co., Ltd. (JP) | 1984-08-08 | — | — | EP | disclosed |
| EP-0114899-A1 | 2-Methylchromone derivatives and their preparation process | Eisai Co., Ltd. (JP) | 1984-08-08 | — | — | EP | disclosed |
| EP-0114899-A1 | 2-Methylchromone derivatives and their preparation process | Eisai Co., Ltd. (JP) | 1984-08-08 | — | — | EP | disclosed |
| US-4428955-A | ALLERGIC DISEASES | BOEHRINGER MANNHEIM GMBH (DE) | 1984-01-31 | — | — | US | disclosed |
| JP-S06330483-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | STING1, IRF3, CGAS | TNKS 342/4885PARP1 2212/4885TNKS2 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.